117 related articles for article (PubMed ID: 7662637)
1. Ischaemic retinopathy occurring in patients receiving bone marrow allografts and campath-1G: a clinicopathological study.
Webster AR; Anderson JR; Richards EM; Moore AT
Br J Ophthalmol; 1995 Jul; 79(7):687-91. PubMed ID: 7662637
[TBL] [Abstract][Full Text] [Related]
2. Severe migratory polyarthritis following in vivo CAMPATH-1G.
Varadi G; Or R; Rund D; Orbach H; Slavin S; Nagler A
Bone Marrow Transplant; 1995 Dec; 16(6):843-5. PubMed ID: 8750280
[TBL] [Abstract][Full Text] [Related]
3. Atypical retinal microvasculopathy after bone marrow transplantation.
Bylsma GW; Hall AJ; Szer J; West R
Clin Exp Ophthalmol; 2001 Aug; 29(4):225-9. PubMed ID: 11545420
[TBL] [Abstract][Full Text] [Related]
4. Rare retinal complications of bone marrow transplantation (BMT): a case report.
Butt F; McKibbin M
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):225. PubMed ID: 30255790
[TBL] [Abstract][Full Text] [Related]
5. T cell depletion by exposure to Campath-1G in vitro prevents graft-versus-host disease.
Jacobs P; Wood L; Fullard L; Waldmann H; Hale G
Bone Marrow Transplant; 1994 Jun; 13(6):763-9. PubMed ID: 7920312
[TBL] [Abstract][Full Text] [Related]
6. Campath-1G in vivo confers a low incidence of graft-versus-host disease associated with a high incidence of mixed chimaerism after bone marrow transplantation for severe aplastic anaemia using HLA-identical sibling donors.
Hamblin M; Marsh JC; Lawler M; McCann SR; Wickham N; Dunlop L; Ball S; Davies EG; Hale G; Waldmann H; Gordon-Smith EC
Bone Marrow Transplant; 1996 May; 17(5):819-24. PubMed ID: 8733704
[TBL] [Abstract][Full Text] [Related]
7. Multiple cotton wool spots following bone marrow transplantation for treatment of acute lymphatic leukaemia.
Gloor B; Gratwohl A; Hahn H; Kretzschmar S; Robert Y; Speck B; Daicker B
Br J Ophthalmol; 1985 May; 69(5):320-5. PubMed ID: 3888252
[TBL] [Abstract][Full Text] [Related]
8. Infantile case of occlusive microvascular retinopathy after bone marrow transplantation.
Kawase E; Azuma N; Shioda Y; Kumagai M
Jpn J Ophthalmol; 2005; 49(4):318-20. PubMed ID: 16075334
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of CAMPATH-1H in BMT patients.
Rebello P; Cwynarski K; Varughese M; Eades A; Apperley JF; Hale G
Cytotherapy; 2001; 3(4):261-7. PubMed ID: 12171714
[TBL] [Abstract][Full Text] [Related]
10. Campath-1G. Campath IgG, Campath-1-IgG antibody.
Drugs R D; 1999 Jan; 1(1):71-2. PubMed ID: 10565991
[No Abstract] [Full Text] [Related]
11. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia.
Lowdell MW; Craston R; Ray N; Koh M; Galatowicz G; Prentice HG
Bone Marrow Transplant; 1998 Apr; 21(7):679-86. PubMed ID: 9578307
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow transplantation retinopathy.
Gómez-Ulla F; Rodríguez-Cid MJ; Gómez-Torreiro M; Abelenda D
Int Ophthalmol; 2001; 24(1):33-5. PubMed ID: 11998885
[TBL] [Abstract][Full Text] [Related]
13. In vivo use of Campath-1G to prevent graft-versus-host disease and graft rejection after bone marrow transplantation.
Willemze R; Richel DJ; Falkenburg JH; Hale G; Waldmann H; Zwaan FE; Fibbe WE
Bone Marrow Transplant; 1992 Apr; 9(4):255-61. PubMed ID: 1600413
[TBL] [Abstract][Full Text] [Related]
14. Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies.
Siegal D; Xu W; Sutherland R; Kamel-Reid S; Kuruvilla J; Lipton JH; Minden M; Messner H; Gupta V
Bone Marrow Transplant; 2008 Jul; 42(1):51-6. PubMed ID: 18372907
[TBL] [Abstract][Full Text] [Related]
15. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center.
Gennery AR; Dickinson AM; Brigham K; Barge D; Spickett GP; Curtis A; Spencer V; Jackson A; Cavanagh G; Carter V; Palmer P; Flood TJ; Cant AJ; Abinun M
Cytotherapy; 2001; 3(3):221-32. PubMed ID: 12171729
[TBL] [Abstract][Full Text] [Related]
16. Ocular complications of pediatric bone marrow transplantation.
Ng JS; Lam DS; Li CK; Chik KW; Cheng GP; Yuen PM; Tso MO
Ophthalmology; 1999 Jan; 106(1):160-4. PubMed ID: 9917798
[TBL] [Abstract][Full Text] [Related]
17. Retinal microvascular changes following bone marrow transplantation: the role of cyclosporine.
O'Riordan JM; FitzSimon S; O'Connor M; McCann SR
Bone Marrow Transplant; 1994 Jan; 13(1):101-4. PubMed ID: 8019445
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow infarction due to acute graft-versus-host disease in an acute lymphoblastic leukemia patient after unrelated bone marrow transplantation.
Mori A; Hashino S; Imamura M; Kahata K; Kawakami H; Shibata M; Kobayashi S; Tanaka J; Asaka M
Bone Marrow Transplant; 1998 Mar; 21(6):615-7. PubMed ID: 9543066
[TBL] [Abstract][Full Text] [Related]
19. Control of graft-versus-host disease and graft rejection by T cell depletion of donor and recipient with Campath-1 antibodies. Results of matched sibling transplants for malignant diseases.
Hale G; Waldmann H
Bone Marrow Transplant; 1994 May; 13(5):597-611. PubMed ID: 8054913
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplant retinopathy.
Lopez PF; Sternberg P; Dabbs CK; Vogler WR; Crocker I; Kalin NS
Am J Ophthalmol; 1991 Dec; 112(6):635-46. PubMed ID: 1957898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
